The new initiative aims to improve early detection by increasing access to screening in communities where accessing care is ...
Some patients in the UK with chronic kidney disease (CKD) who develop chronic ... NICE based its decision on two phase 3 trials, KALM-1 and KALM-2, which showed that treatment with Kapruvia ...